CHMP4C and cervical cancer: As for RRAGB, Shi et al. successfully constructed a signature based on CHMP4C, FOXO1, RRAGB to effectively predict the cervical cancer patients’ prognosis [13] and Xie et al. also constructed a six-gene model including RRAGB predict the non-small-cell lung cancer patients’ overall survival (OS) [14].